Keros Therapeutics (KROS) Return on Sales (2019 - 2025)
Keros Therapeutics (KROS) reported Return on Sales of 0.41% for Q4 2025, down 131.0% on a YoY basis from 1.31% in Q4 2024, and down 7865.62% quarter-over-quarter from 0.01% in Q3 2025.
Keros Therapeutics (KROS) Return on Sales (2019 - 2025) Analysis & Trends
Keros Therapeutics has reported Return on Sales for 7 years, with the latest figure at 0.41% in Q4 2025.
- For the quarter ending Q4 2025, Return on Sales fell 131.0% year-over-year to 0.41%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (down 1561.0% YoY), and the FY2025 full-year result was 0.0%, changed N/A from the prior year.
- Return on Sales for Q4 2025 stood at 0.41%, down from 0.01% in the prior quarter.
- The five-year high for Return on Sales was 0.91% in Q4 2024, with the low at 54.1% in Q3 2023.
- Historically, Return on Sales has averaged 5.26% across 5 years, with a median of 0.06% in 2022.
- Annual changes were most pronounced in 2023 — Return on Sales sank 5408 bps — and 2024, when it jumped 5274 bps.
- Keros Therapeutics' Return on Sales stood at 0.0% in 2021, then tumbled by 1400 bps to 0.06% in 2022, then sank by 5486 bps to 3.25% in 2023, then surged by 128 bps to 0.91% in 2024, then sank by 145 bps to 0.41% in 2025.
- The last three Return on Sales figures came in at 0.41% (Q4 2025), 0.01% (Q3 2025), and 0.02% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Keros Therapeutics | 399.01 Mn | 111.61 Mn | - | -0.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.41% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 0.91% |
| Sep 30, 2024 | -1.36% |
| Jun 30, 2024 | -11.80% |
| Mar 31, 2024 | -11.54% |
| Dec 31, 2023 | -3.25% |
| Sep 30, 2023 | -54.10% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -6.25% |
| Jun 30, 2021 | -1.56% |
| Sep 30, 2020 | -0.15% |
| Jun 30, 2020 | -0.06% |
| Mar 31, 2020 | -0.03% |